Aliskiren

被引：6

作者：

Kappert, K. ^{[1
]}

Unger, T. ^{[1
]}

Kintscher, U. ^{[1
]}

机构：

[1] Charite Univ Med Berlin, Inst Pharmakol, Cardiovasc Res Ctr, D-10115 Berlin, Germany

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2008年 / 133卷 / 24期

关键词：

galiskiren; renin; angiotensin; renin-angiotensin-systern; hypertension;

D O I：

10.1055/s-2008-1077232

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

[No abstract available]

引用

收藏

页码：1308 / 1312

页数：5

相关论文

共 21 条

[1]

ASSOCIATION OF THE RENIN SODIUM PROFILE WITH THE RISK OF MYOCARDIAL-INFARCTION IN PATIENTS WITH HYPERTENSION [J].

ALDERMAN, MH ;

MADHAVAN, S ;

OOI, WL ;

COHEN, H ;

SEALEY, JE ;

LARAGH, JH .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (16) :1098-1104

[2]

Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial [J].

Andersen, Karl ;

Weinberger, Myron H. ;

Egan, Brent ;

Constance, Christian M. ;

Ali, Mohammed A. ;

Jine, James ;

Keefe, Deborah L. .

JOURNAL OF HYPERTENSION, 2008, 26 (03) :589-599

[3]

*FDA, FDA LAB INF

[4]

Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide [J].

Feldt, Sandra ;

Batenburg, Wendy W. ;

Mazak, Istvan ;

Maschke, Ulrike ;

Wellner, Maren ;

Kvakan, Heda ;

Dechend, Ralf ;

Fiebeler, Anette ;

Burckle, Celine ;

Contrepas, Aurelie ;

Danser, A. H. Jan ;

Bader, Michael ;

Nguyen, Genevieve ;

Luft, Friedrich C. ;

Muller, Dominik N. .

HYPERTENSION, 2008, 51 (03) :682-688

[5]

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients [J].

Gradman, AH ;

Schmieder, RE ;

Lins, RL ;

Nussberger, J ;

Chiang, YT ;

Bedigian, MP .

CIRCULATION, 2005, 111 (08) :1012-1018

[6]

Antihypertensive therapy with aliskiren [J].

Luft, F. C. ;

Weinberger, M. H. .

KIDNEY INTERNATIONAL, 2008, 73 (06) :679-683

[7]

Ménard J, 2007, J HYPERTENS, V25, P1775

[8]

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin [J].

Nguyen, G ;

Delarue, F ;

Burcklé, C ;

Bouzhir, L ;

Giller, T ;

Sraer, JD .

JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (11) :1417-1427

[9]

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100) - Comparison with enalapril [J].

Nussberger, J ;

Wuerzner, G ;

Jensen, C ;

Brunner, HR .

HYPERTENSION, 2002, 39 (01) :E1-E8

[10]

Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension [J].

Oh, Byung-Hee ;

Mitchell, Jerry ;

Herron, James R. ;

Chung, Jenny ;

Khan, Mahmudul ;

Keefe, Deborah L. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (11) :1157-1163